ProMed Pharma LLC operates as a contract development and manufacturing organisation (CDMO) focused on complex, polymer-based dosage forms. Established in 2006, the company built on ProMed Molded Products’ three decades of experience in moulding intricate medical-device components. With nearly 20 years of operational history in pharmaceutical development, ProMed Pharma has become proficient in extended-release dosing using techniques such as moulding, extrusion, and microencapsulation across a broad range of polymer types—including silicones, thermoplastics, and biodegradables. The firm serves emerging biotech and global pharmaceutical clients, delivering solutions from early-stage feasibility through to commercial manufacturing with rapid project execution grounded in scientific rigour and technical finesse.

Key Products and Services:

Polymers for Controlled Release: Use of biocompatible materials—silicones, EVA, polyurethanes, acrylate hydrogels, PLGA—for precision drug release (typical drug loading 5–50% by weight)

Manufacturing Techniques: Injection moulding (silicone and plastic), hot-melt extrusion, microencapsulation (microspheres)

Handling of Diverse APIs: Expertise with steroids, hormones, antibiotics, microbicides, prostaglandins, small molecules, peptides, and macromolecules such as mAbs and siRNA

Solutions Offered:

• Drug-product feasibility assessments
• Tech-transfer, process optimisation and scale-up
• cGMP manufacturing
• Device assembly, packaging, sterilisation
• Analytical and stability testing

Applications: Tailored controlled-release systems for ophthalmology, women’s health, oncology, drug-device combination products, macromolecule delivery, ENT, cardiovascular, local drug delivery and more.

Facilities & Quality Systems: Clean-room environment including Class 10,000 areas and Class 5 isolators, >10,000 sq ft manufacturing space, design-for-manufacturing and assembly support, and quality systems compliant with FDA (21 CFR 210/211, 820), ISO 13485, with a strong inspection record.

ProMed Pharma LLC stands as a mature and versatile CDMO partner in controlled-release drug delivery. The company’s technical capabilities, rich polymer science expertise, and robust quality infrastructure support clients from early formulation through to commercial scale. With its long-standing history and commitment to precision in drug delivery, ProMed Pharma is well-positioned to serve a broad range of pharmaceutical and biotech customers seeking tailored, reliable dosage form solutions.